Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 18041 - 18050 of 24215
Identification Number | Trade Name | Benefit Category |
---|---|---|
02423251 | SANDOZ QUETIAPINE XR EXTENDED RELEASE TAB 400MG | Standard Benefit for Eligible Clients |
02423278 | MYLAN-CELECOXIB CAP 100MG | Standard Benefit for Eligible Clients |
02423286 | MINT-GLICLAZIDE MR TAB 30MG | Standard Benefit for Eligible Clients |
02423294 | MINT-GLICLAZIDE MR TAB 60MG | Standard Benefit for Eligible Clients |
02423308 | MINT-TOLTERODINE TAB 1MG | Standard Benefit for Eligible Clients |
02423316 | MINT-TOLTERODINE TAB 2MG | Standard Benefit for Eligible Clients |
02423324 | MYLAN-CANDESARTAN HCTZ TAB 32MG/12.5MG | Standard Benefit for Eligible Clients |
02423332 | MYLAN-CANDESARTAN HCTZ TAB 32MG/25MG | Standard Benefit for Eligible Clients |
02423375 | APO-SOLIFENACIN TAB 5MG | Standard Benefit for Eligible Clients |
02423383 | APO-SOLIFENACIN TAB 10MG | Standard Benefit for Eligible Clients |
Displaying 18041 - 18050 of 24215